As the FTSE 100 and FTSE 250 indices reflect the impact of global economic challenges, notably from China’s sluggish recovery, investors are navigating a complex landscape in the UK market. In such conditions, identifying stocks that may be undervalued can present opportunities for those looking to capitalize on potential market inefficiencies.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
XP Power (LSE:XPP) |
£13.40 |
£23.68 |
43.4% |
|
Taylor Wimpey (LSE:TW.) |
£0.8822 |
£1.75 |
49.7% |
|
Pinewood Technologies Group (LSE:PINE) |
£2.19 |
£4.12 |
46.8% |
|
Pan African Resources (LSE:PAF) |
£1.57 |
£3.11 |
49.5% |
|
James Fisher and Sons (LSE:FSJ) |
£4.99 |
£9.22 |
45.9% |
|
Fevertree Drinks (AIM:FEVR) |
£8.225 |
£15.73 |
47.7% |
|
Eurocell (LSE:ECEL) |
£1.16 |
£2.11 |
44.9% |
|
Entain (LSE:ENT) |
£5.842 |
£10.42 |
44% |
|
ACG Metals (LSE:ACG) |
£14.80 |
£26.72 |
44.6% |
|
Accsys Technologies (AIM:AXS) |
£0.606 |
£1.16 |
47.6% |
Underneath we present a selection of stocks filtered out by our screen.
Overview: Fevertree Drinks PLC, along with its subsidiaries, develops and sells mixer drinks in the UK, US, Europe, and internationally with a market cap of £949.12 million.
Operations: The company’s revenue segments include £131.90 million from the US and £243.40 million from the rest of the group.
Estimated Discount To Fair Value: 47.7%
Fevertree Drinks appears undervalued based on cash flow analysis, trading at £8.23, which is 47.7% below its estimated fair value of £15.73. Despite recent declines in sales and net income for 2025, the company is projected to experience significant earnings growth of 20.9% annually over the next three years, outpacing the UK market average. Revenue growth is also expected to surpass the market at 10.2% per year, supporting its potential as a value investment opportunity in cash flow terms.
Overview: CVS Group plc operates veterinary services, an online pharmacy, and retail businesses in the United Kingdom and Australia, with a market cap of £833.46 million.
Operations: The company’s revenue segments include £632.70 million from veterinary practices, £33 million from laboratories, and £47.90 million from its online retail business.
Estimated Discount To Fair Value: 30.8%
CVS Group, trading at £11.88, is considered undervalued on a cash flow basis with an estimated future value of £17.17, representing a discount exceeding 20%. Despite recent declines in net income for the half year ending December 2025, CVS is expected to achieve significant annual earnings growth of 21%, outpacing the UK market average. However, it carries a high debt level and its revenue growth forecast of 4.6% per year slightly exceeds market expectations.
Overview: Pan African Resources PLC is involved in the mining, extraction, production, and sale of gold in South Africa with a market cap of approximately £3.18 billion.
Operations: The company’s revenue is primarily derived from its operations at Evander Mines ($330.02 million), Barberton Mines ($289.61 million), and MTR Projects ($155.43 million), along with a minor contribution from Agricultural ESG Projects ($0.62 million).
Estimated Discount To Fair Value: 49.5%
Pan African Resources, trading at £1.57, is significantly undervalued based on cash flows with an estimated future value of £3.11. Recent earnings reports show substantial growth, with net income rising to US$147.97 million for the half year ending December 2025 from US$48.22 million a year prior. Forecasts suggest robust annual earnings growth of 26.5%, surpassing UK market averages, while revenue is expected to grow at 12% per year amidst a volatile share price history.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:FEVR LSE:CVSG and LSE:PAF.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
















